Purpose

This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

Condition

Eligibility

Eligible Ages
Between 18 Years and 64 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 to <65 years - Migraine with or without aura, per ICHD-3 criteria - History of failure with prior preventive migraine treatments - Not currently using migraine preventive therapy

Exclusion Criteria

  • Difficulty distinguishing migraine from other headache types or presence of other primary headache disorders - Use of certain medications - Any clinically significant medical, psychiatric, neurological, cardiovascular, or laboratory abnormalities

Study Design

Phase
Phase 2
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Dose 1
Orally administered EVO756, Dose 1 (Daily)
  • Drug: EVO756, Dose 1
    Orally administered EVO756, Dose 1 (Daily)
Experimental
Dose 2
Orally administered EVO756, Dose 2 (Daily)
  • Drug: EVO756, Dose 2
    Orally administered EVO756, Dose 2 (Daily)
Placebo Comparator
Placebo
Placebo control (Daily)
  • Drug: Placebo
    Placebo Control (Daily)

Recruiting Locations

Trialsphere Corp
Chandler, Arizona 85286

Neuro Pain Research Center
Fresno, California 93710
Contact:
EVO756-MIG001 Research Site
5594379700
lflores@neuropain.com

CA Medical Clinic for Headache
Los Angeles, California 90067
Contact:
EVO756-MIG001 Research Site
(323)879-9999
jlatorre@clinicalri.net

Diablo Clinical Research dba Flourish Research
Walnut Creek, California 94598
Contact:
EVO756-MIG001 Research Site
9259307267
kabdullah@flourishresearch.com

New England Institute for Neurology and Headache
Stamford, Connecticut 06905
Contact:
EVO756-MIG001 Research Site
203-914-1903
annelise@neinh.com

Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida 32256
Contact:
EVO756-MIG001 Research Site
904-281-5757
bsagil@cnshealthcare.com

Apple Medical Research Group, Inc
Miami, Florida 331216
Contact:
EVO756-MIG001 Research Site
3056678434
info@applemedresearch.org

Clinical Neuroscience Solutions, Inc.
Orlando, Florida 32819
Contact:
(407) 425-5100
orlinfo@cnshealthcare.com

Accel Research Site-Decatur-Alcanza
Decatur, Georgia 30030
Contact:
EVO756-MIG001 Research Site
404-475-0552
benoit.tete@accelclinical.com

Michigan Headache and Neurological Institute
Ann Arbor, Michigan 48104
Contact:
EVO756-MIG001 Research Site
734-677-6000
research@mhni.com

Bio Behavoural health
Toms River, New Jersey 08755
Contact:
732-244-2299
jryan@bbhnj.com

Clinosis - Dent Neurologic Instite
Amherst, New York 14226
Contact:
EVO756-MIG001 Research Site
716-250-2017
abryan@dentinstitute.com

Asheville Neurology Specialists, Pa
Asheville, North Carolina 28806
Contact:
EVO756-MIG001 Research Site
(828) 210-9306
amberc@ashneuro.com

Eximia Research NC
Raleigh, North Carolina 27607
Contact:
EVO756-MIG001 Research Site
(919) 800-5154
achambers@eximiaresearch.com

Clinical Trials of South Carolina
Charleston, South Carolina 29406
Contact:
EVO756-MIG001 Research Site
843-725-5067
Info@clinicaltrialssc.com

FutureSearch Trials of Neurology
Austin, Texas 78731
Contact:
EVO756-MIG001 Research Site
(512) 380-9925
ATXClinic@fstrials.com

FutureSearch Trials of Dallas
Dallas, Texas 75251
Contact:
EVO756-MIG001 Research Site
214-361-7700
dallasleads@fstrials.com

SFF Medical Research Group LLC
Houston, Texas 77018
Contact:
EVO756-MIG001 Research Site
(832) 533-8872
nichole.baio@evommune.com

Vaught Neurological Services
Crab Orchard, West Virginia 25827
Contact:
EVO756-MIG001 Research Site
304-252-4222
research@vaughtneurology.com

More Details

Status
Recruiting
Sponsor
Evommune, Inc.

Study Contact

Nichole Baio
(650) 319-4553
nichole.baio@evommune.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.